Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-101.49M
↓ 51% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-67.27M
Historical baseline
PeriodValueYoY Change
TTM$-101.49M-0.5%
2024$-100.97M+0.7%
2023$-101.68M-66.7%
2022$-61.00M-23.6%
2021$-49.35M-34.7%
2020$-36.63M+46.6%
2019$-68.64M-273.3%
2018$-18.39M-